- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05731310
Clinical Study of Angong Niuhuang Pill and Acupuncture on PSCI Angong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
Efficacy Evaluation and Evaluation of Peripheral Neuroprotective Mechanism of Amgong Niuhuang Pill Combined With Supervised Pulse Music Electroacupuncture on Cognitive Impairment After Ischemic Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
(1) Clinical scale data of cognitive function, daily living ability of PSCI patients integrated with the research of this project using uterine Niu Huang pill combined with examined pulse music electroacupuncture
For analysis, the efficacy of PSCI patients was observed; (2) In depth studies on auditory event-related potentials of PSCI treated by uterine Niu Huang pill combined with examined pulse music electroacupuncture
The changes of serum related nerve growth factor and the relationship between each other in order to enrich / fill our province's research results in this field; (3) In key academic journals
1 high level scientific research paper published.
Study Type
Enrollment (Anticipated)
Phase
- Early Phase 1
Contacts and Locations
Study Contact
- Name: le zhang
- Phone Number: 86-13616511229
- Email: 2319053@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Recruiting
- 2nd Affiliated Hospital, School of Medicine
-
Contact:
- le zhang
- Phone Number: 86-13616511229
- Email: 2319053@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
(1) All were the first stroke, confirmed by head computed tomography (CT) or magnetic resonance imaging (MRI), with vital signs
stable; (2) Those who are conscious and can cooperate with relevant treatment; (3) Montreal Cognitive Assessment Scale (MoCA) score ≤ 24 points; (4)
The course of disease is more than 1 month, and the patient is 40-70 years old.
Exclusion Criteria:
(1) People with cognitive impairment before onset; (2) There are contraindications of Angong Niuhuang Pill or electroacupuncture treatment;
(3) Complicated with dysfunction of heart, liver, kidney and other important organs; (4) Previous history of cerebral hemorrhage, epilepsy, brain injury, etc; (5) Before onset
Have a history of alcohol and drug dependence; (6) The condition worsens, and new hemorrhagic or infarcted foci appear.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Angong Niuhuang Pill Group
Take half an Angong Niuhuang pill every day for 4 weeks
|
Take Angong Niuhuang pill half a pill/day; Angong Niuhuang pill combined with music scalp acupuncture group These operations last for 4 weeks
Other Names:
|
Experimental: Angong Niuhuang pill combined with music electroacupuncture group
Take half an Angong Niuhuang pill every day for 4 weeks and Daily music scalp acupuncture treatment
|
Take Angong Niuhuang pill half a pill/day; Angong Niuhuang pill combined with music scalp acupuncture group These operations last for 4 weeks
Other Names:
|
No Intervention: General control group
no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Simple intelligence state examination scale
Time Frame: up to 4 weeks
|
MMSE
|
up to 4 weeks
|
Collaborators and Investigators
Investigators
- Study Chair: le zhang, 2nd Affiliated Hospital, School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0507
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-stroke Cognitive Impairment
-
Samsung Medical CenterCompletedPost-stroke Cognitive ImpairmentKorea, Republic of
-
The Third Affiliated hospital of Zhejiang Chinese...RecruitingPost-stroke Cognitive ImpairmentChina
-
Chang Gung Memorial HospitalRecruitingNeuroinflammation | Post-stroke Cognitive ImpairmentTaiwan
-
Tel-Aviv Sourasky Medical CenterHadassah Medical Organization; Soroka University Medical CenterRecruitingPost Stroke Cognitive ImpairmentIsrael
-
TakedaCompletedPost-Stroke Cognitive Impairment (PSCI)Belarus, Kazakhstan, Russian Federation
-
Beijing Tiantan HospitalNot yet recruitingIschemic Stroke | Post-stroke Cognitive Impairment
-
Shanghai University of Traditional Chinese MedicineRecruitingPost-stroke Mild Cognitive ImpairmentChina
-
Simcere Pharmaceutical Co., LtdNot yet recruitingPost-stroke Cognitive ImpairmentChina
-
Hui-Sheng ChenCompletedPost-stroke Cognitive Impairment | Oxidative-reduction HomeostasisChina
-
AZTherapies, Inc.WithdrawnIschemic Stroke | Post-stroke Cognitive Impairment
Clinical Trials on Angong Niuhuang Pill
-
Peking Union Medical College HospitalCompletedAcute Ischemic StrokeChina
-
Chinese University of Hong KongRecruiting
-
University of Alabama at BirminghamCompletedObesity | Body Weight | Eating Behavior | HungerUnited States
-
Peking Union Medical College HospitalThe Second Hospital of Hebei Medical University; China-Japan Friendship Hospital and other collaboratorsUnknownAcute Ischemic StrokeChina
-
NYU Langone HealthCompleted
-
Guangzhou University of Traditional Chinese MedicineUnknownPost-stroke Patients With Motor and Sensory DysfunctionChina
-
Massachusetts General HospitalGaneden Biotech, Inc.TerminatedIrritable Bowel Syndrome | Major Depressive DisorderUnited States
-
Hvidovre University HospitalNot yet recruitingCirrhosis, Liver | Procedural Bleeding | Thrombocytopenia; Drugs
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaboratorsTerminated
-
Shanghai Jiao Tong University School of MedicineShanghai University of Traditional Chinese MedicineRecruitingPresbycusis | Age-related Hearing Loss | Hearing Disorders and DeafnessChina